Newsfeeds - Spark Newswire

2 minute read

News

Codex DNA Announces Commercial Availability Of Automated mRNA Synthesis Kit With Integrated Capping Technology For BioXp System

Today, 2:30 PM

Codex DNA, Inc. (NASDAQ:DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the commercial launch of its BioXp™ mRNA synthesis kits with CleanCap® Reagent AG, a proprietary mRNA

DNAY

6 minute read

56 Biggest Movers From Friday

By Lisa Levin

Today, 2:30 PM

Gainers

ADGI

6 minute read

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance

By Shanthi Rexaline

Today, 2:30 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ACIU

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 2:30 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

2 minute read

FDA
News

Maravai LifeSciences Holdings Says New England Biolabs Releases Next Generation HiScribe In Vitro Transcription Kit, Incorporating TriLink Biotechnologies’ CleanCap Technology For mRNA Synthesis

By Benzinga Newsdesk

Today, 2:30 PM

New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai

MRVI

7 minute read

92 Biggest Movers From Friday

By Lisa Levin

Today, 2:30 PM

Gainers

AAOI

1 minute read

News

Maravai LifeSciences Announced New European Patent

By Charles Gross

Today, 2:30 PM

Maravai LifeSciences, Inc. (NASDAQ: MRVI) announced today that the European Patent Office has issued a new patent, No. 3352584, to the company's TriLink BioTechnologies subsidiary.

MRVI